Lead neurotoxicity in children: is prenatal exposure more important than postnatal exposure?

Roberto Ronchetti1, Peter van den Hazel, Greet Schoeters

  • 1Department of Paediatrics, Second School of Medicine, University 'La Sapienza', Rome, Italy. roberto.ronchetti@ospedalesantandrea.it

Insights

Even low lead exposure can impact children's IQ. Maternal lead stores, not just current intake, are crucial for prenatal neurotoxicity, suggesting a focus on reducing bone resorption during pregnancy.

Area of Science:

  • Environmental Health
  • Neurotoxicology
  • Pediatrics

Background:

  • Low-level lead poisoning is linked to reduced cognitive function in children.
  • Current European adult lead intake is generally low, but concerns persist regarding children's blood lead levels (PbB).
  • Recent findings suggest an inverse association between blood lead concentration and IQ scores, even below 10 microg/dl.

Purpose of the Study:

  • To investigate the impact of lead exposure on children's intelligence.
  • To evaluate the role of maternal lead stores and prenatal exposure in neurotoxicity.
  • To explore strategies for reducing lead mobilization during pregnancy.

Main Methods:

  • Review of existing studies on lead exposure and cognitive function.
  • Analysis of lead contribution from tissue stores versus current intake.
  • Focus on prenatal lead exposure and maternal bone lead levels.

Main Results:

  • Lead in blood originates significantly from long-term tissue stores, particularly in pregnant women and infants.
  • Prenatal exposure is a critical factor in lead's neurotoxic effects.
  • Maternal bone lead stores may be a key predictor of neurotoxicity.

Conclusions:

  • Focusing on maternal lead stores and preventing their mobilization during pregnancy is essential.
  • Dietary supplementation studies are needed to assess their efficacy in reducing lead mobilization.
  • Future research on children with low maternal bone lead stores may clarify lead's population-level impact on IQ.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...